Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-013092

Director acquired 2,800 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-09-18 Other acquisition 10b5-1 +280 $2.03 $568 216,646 D
Krogulski Kenneth Director 2023-09-19 Other acquisition 10b5-1 +280 $2.12 $594 216,926 D
Krogulski Kenneth Director 2023-09-20 Other acquisition 10b5-1 +280 $2.14 $599 217,206 D
Krogulski Kenneth Director 2023-09-21 Other acquisition 10b5-1 +280 $2.28 $638 217,486 D
Krogulski Kenneth Director 2023-09-22 Other acquisition 10b5-1 +280 $2.29 $641 217,766 D
Krogulski Kenneth Director 2023-09-25 Other acquisition 10b5-1 +280 $2.24 $627 218,046 D
Krogulski Kenneth Director 2023-09-26 Other acquisition 10b5-1 +280 $2.07 $580 218,326 D
Krogulski Kenneth Director 2023-09-27 Other acquisition 10b5-1 +280 $1.98 $554 218,606 D
Krogulski Kenneth Director 2023-09-28 Other acquisition 10b5-1 +280 $1.96 $549 218,886 D
Krogulski Kenneth Director 2023-09-29 Other acquisition 10b5-1 +280 $1.90 $532 219,166 D
Loading xslF345X05/marketforms-62742.xml…